产品名称
GC-RICH PCR System, dNTPack, suitable for PCR, hotstart: no, Difficult Templates/Specialty Enzymes PCR
usage
sufficient for ≤50 reactions
feature
Difficult Templates/Specialty Enzymes PCR
dNTPs included
hotstart: no
packaging
pkg of 100 U
manufacturer/tradename
Roche
parameter
72 °C optimum reaction temp.
technique(s)
PCR: suitable
input
purified DNA
shipped in
dry ice
storage temp.
−20°C (−15°C to −25°C)
Analysis Note
The GC-RICH PCR System is function-tested, by amplifying a human 284 bp ApoE genomic fragment, using the GC-RICH PCR System protocols.
Application
The GC-RICH PCR System, a blend of Taq DNA Polymerase and a proofreading polymerase, enables amplification of templates that are difficult or impossible to amplify with other polymerases and other blends of polymerases. The enhanced processivity of the blend and the unique GC-RICH Resolution Solution combine to deliver superior performance – especially from problematic templates.
The GC-RICH PCR System, dNTPack may also be used in standard PCR applications, providing improved results (higher yield, higher accuracy) over Taq DNA Polymerase alone.
The GC-RICH PCR System, dNTPack may also be used in standard PCR applications, providing improved results (higher yield, higher accuracy) over Taq DNA Polymerase alone.
Features and Benefits
- Ease access to difficult templates:-
- Reagents, the GC-RICH Resolution Solution and PCR Grade Water are provided.
- Amplify DNA fragments up to 5 kb.
- Cost-effective:-
General description
The GC-RICH PCR System, dNTPack is composed of a special enzyme blend of thermostable Taq DNA Polymerase and Tgo DNA Polymerase, a thermostable enzyme with a proofreading (3′-5′ exonuclease) activity. This polymerase mixture by itself outperforms Taq DNA Polymerase in respect to yields, fidelity and specificity beside the possibility to amplify fragments up to 5 kb in length. The GC-RICH PCR reaction buffer in combination with the included GC-RICH resolution solution allows to amplify very efficiently difficult templates like GC-rich targets.
Legal Information
Use of this product is covered by US patent claims and corresponding patent claims outside the US. The purchase of this product includes a limited, non-transferable immunity from suit under the foregoing patent claims for using only this amount of product for the purchaser′s own internal research. No right under any other patent claim, no right to perform any patented method, and no right to perform commercial services of any kind, including without limitation reporting the results of purchaser′s activities for a fee or other commercial consideration, is conveyed expressly, by implication, or by estoppel. This product is for research use only. Diagnostic uses under Roche patent claims require a separate license from Roche. Further information on purchasing licenses may be obtained by contacting the Director of Licensing, Applied Biosystems, 850 Lincoln Centre Drive, Foster City, California 94404, USA.
Other Notes
For life science research only. Not for use in diagnostic procedures.
Volume Activity: 2 U/μl
Packaging
1 kit containing 6 components
Preparation Note
Working concentration: The optimal enzyme concentration range from 0.5 to 5 U per assay. For a standard 50 μl PCR, we recommend using 2 U of the enzyme blend.
hcodes
pcodes
Hazard Classifications
Aquatic Chronic 3
存储类别
12 - Non Combustible Liquids
wgk
WGK 2
flash_point_f
does not flash
flash_point_c
does not flash
法规信息
常规特殊物品
此项目有
Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes
Abaigar, et al.
PLoS ONE, 11 (2016)
Jenny Rinke et al.
Clinical chemistry, 59(8), 1238-1250 (2013-04-18)
We sought to establish a convenient, sensitive next-generation sequencing (NGS) method for genotyping the 26 most commonly mutated leukemia-associated genes in a single work flow and to optimize this method for low amounts of input template DNA. We designed 184
Distribution of Giardia duodenalis assemblages A and B among children living in a remote indigenous community of the Northern Territory, Australia
Asher, et al.
PLoS ONE, 9 (2014)
Laurianne Davignon et al.
Human molecular genetics, 25(8), 1559-1573 (2016-03-25)
Despite recent progress in the genetic characterization of congenital muscle diseases, the genes responsible for a significant proportion of cases remain unknown. We analysed two branches of a large consanguineous family in which four patients presented with a severe new
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持